Stage III oral cavity cancer is characterized by larger tumors or lymph node involvement, often diagnosed through physical ...

AstraZeneca and Daiichi Sankyo’s Enhertu's breakthrough therapy designation as a post-neoadjuvant treatment option for ...

A new case report published in Annals of Internal Medicine describes a novel approach for treating fibrosing mediastinitis ...

A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has developed and validated an artificial intelligence (AI)–based noninvasive tool that can predict the likelihood ...

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, ...

A team led by investigators at Dana-Farber Cancer Institute and Mass General Brigham has developed and validated an artificial intelligence (AI)-based ...

The FDA has granted breakthrough therapy designation (BTD) to fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) for the ...

Arizona state Senator Wendy Rogers has introduced legislation and a constitutional amendment to exempt virtual currency from ...

Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients ...

AstraZeneca reports a Phase 3 lung cancer miss, FDA breakthrough status for Enhertu, and a $2 billion KRAS drug deal with ...

Syphilis spreads primarily through vaginal, anal or oral sex, Shen explains. Condoms greatly reduce risk, but they do not ...

The current melanoma staging system does not always reflect actual survival outcomes. In some cases, patients with thick but ...